Wikipedia -WSS

Wikipedia

author：explore 2025-08-12 09:12:04 - browse：652

Adam's take main illustration — Molly Ferguson/STAT

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome.

What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December, Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.

If blarcamesine fails to achieve the pre-determined goals of clinical trials, the thinking apparently goes, then just make a post-hoc change to the study goals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： A deep dive into Applied Therapeutics’ data, and questions on Cassava

entertainment

hotspot

WSS

Mass General, Mayo Clinic look to monetize custom

Air quality improving but still lags in Black, Hispanic communities

FDA sets aggressive timeline for overhauling inspection procedures

HPV vaccine, cervical cancer study delivers historic results

HPV vaccine, cervical cancer study delivers historic results

FDA endorses new sterilization method for medical devices

focus

Wikipedia

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

TikTok, Instagram influencers need more rules for drug ads

State Dept. review finds Biden bears some blame for Afghanistan failures

TikTok, Instagram influencers need more rules for drug ads

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Inaction leaves children at risk from dangerous chemotherapy drug

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Novo Nordisk obesity pill bests Wegovy in early trial

Medical records are filled with copy

Precocious puberty in girls comes with mental health risks

explore

Dana Farber says 6 studies to be retracted and 31 corrected

High breast density mammograms need follow

Novo Nordisk obesity pill bests Wegovy in early trial

The inclusion problem at the heart of rehabilitation research

NEJM study link tiny plastics in blood vessels to heart problems

Head of FDA's diagnostics center, who led through Covid, retires

entertainment

leisure time

hotspot

knowledge